The UK Competition and Markets Authority (CMA) has launched an investigation into Aviva’s acquisition of AIG Life UK, in what formed a £460 million deal.
The watchdog said it is considering whether the takeover will result in a substantial lessening of competition within any market or markets in the UK for goods or services. To assist with the merger inquiry, the CMA has invited comments on the transaction from any interested party. The watchdog will announce its decision on whether to refer the merger for a phase two investigation on 8 April, 2024. An Aviva spokesperson told COVER: "It's typical for transactions to require regulatory approval and this deal is no different. We continue to expect the transaction to complete in the fi...
To continue reading this article...
Join COVER for free
- Unlimited access to real-time news, key trend analysis and industry insights.
- Stay on top of the latest developments around health and wellbeing, diversity and inclusion and the cost of living crisis.
- Receive breaking news stories straight to your inbox in the daily newsletter.
- Members only access to monthly programme 'The COVER Review'
- Be the first to hear about our CPD accredited events and awards programmes.